RyanDe680

Yeah the back and forth is stressful over the years. Simple track one way or the other more than two days out makes one crabby.

Wait till Monday to avoid drama

Talking about on here

Every call busting high

Wow that’s pretty

map guy reincarnated but yeah looks good, lol

where's the guy with the extended period maps? I want my thanksgiving and christmas forecast.

Good thing you went to bed

Thats if the capping further to the south of the line doesn't have an impact

Got that meh feeling

Insane amounts of rain here. Nearly 3” alone this morning.

Slightly under 2” of rain this. Going as predicted

It's been raining for the last 6 hours here, 1.42" in the bank so far.

Lol everyone calling bust and it’s Thursday night

Got about 0.45” on the cook DuPage line

^ lol

Hopeful that this plays out tomorrow.

Thread worthy

Unfortunately there's no way to know the origin of any variant.

Hoping that May picks it up... this is pretty boring w/o severe weather.

Its funny how during the height of the pandemic there weren't as many replies in this thread as there are now with vaccinations....

This may be due to more real world variant exposure...

this is a story of one of my friend's cousin. He's in his 30s, a physician and otherwise healthy https://health.ucdavis.edu/health-news/newsroom/expertise-and-kindness-defy-odds-in-long-precarious-fight-against-covid-19-/2021/04?fbclid=IwAR06yQ7DXdm05nl7z21tHYBYZvP5w-BIo2zQm9WRtmv5wNOl4zPKzQ1VGhE I still don't get why people mess with facts on how bad this can be and NOT want to take safety precautions.

I may have missed this being posted, but good news. Perhaps the smallest study I have seen yet though, lol. Moderna COVID vaccine offers protection for at least 6 months, study finds by Ernie Mundell Healthday Reporter (HealthDay)—There's good news for the millions of Americans who've already received a dose or two of Moderna's COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months. The new study tracked 33 participants in the trials that led to the vaccine's approval. Six months after having received their second vaccine dose, "antibody activity remained high in all age groups," according to a team led by Nicole Doria-Rose of the U.S. National Institute of Allergy and Infectious Diseases (NIAID). Her group published their findings April 6 in the New England Journal of Medicine. The reassuring results follow on similar findings for the other major two-dose vaccine included in the U.S. vaccine rollout, made by Pfizer/BioNTech. Trial results released April 1 by the companies found that their vaccine remains more than 91% effective six months after people get their second dose. The new results from Moderna are based on 33 people ranging in age from 18 to older than 71. The study found that while everyone maintained high levels of infection-fighting immune system antibodies in blood samples, levels did seem to fall according to the increasing age of participants.